|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01789 AK MEDICAL
Nominal 
5.970 +0.090 (+1.531%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 1,346,377 | 23.085% | 1,093,862 | 1,052,047 | 761,441 | 1,035,386 |
| Cost of Sales | (538,184) | 28.330% | (419,376) | (415,612) | (262,252) | (320,854) |
| Gross Profit | 808,193 | 19.824% | 674,486 | 636,435 | 499,189 | 714,532 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | (18,360) | -- | (8,848) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 319,822 | 38.381% | 231,117 | 240,290 | 108,559 | 376,607 | |
| Taxation | (45,896) | -6.360% | (49,013) | (35,518) | (15,940) | (62,600) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 273,926 | 50.423% | 182,104 | 204,772 | 92,619 | 314,007 | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (19,041) | -3.020% | (19,634) | (20,307) | (9,123) | (7,681) |
| Depreciation & Amortisation | 96,334 | 5.933% | 90,939 | 80,401 | 74,158 | 60,521 |
| Directors' Emoluments | -- | -- | 4,580 | 4,307 | 3,746 | 3,150 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 25.000 | 56.250% | 16.000 | 18.000 | 8.000 | 28.000 |
| DPS (cts) | 6.645 | -- | 4.082 | 5.226 | 2.037 | 3.350 |
| Dividend Payout Ratio (%) | 26.581% | -- | 25.510% | 29.036% | 25.460% | 11.964% |
| Cash flow per share ($) | -- | -- | 0.030 | 0.219 | 0.159 | 0.186 |
| NBV per share ($) | 2.350 | -- | 2.132 | 2.011 | 1.821 | 1.831 |
| Remarks: | Real time quote last updated: 11/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 273,926 |
| %Change | 50.423% |
| EPS / (LPS) | RMB 0.250 |
| NBV Per Share (¥) | RMB 2.350 |